NASDAQ: CODXCo Diagnostics Inc Stock
$1.16+0.02 (+1.75%)
Updated Apr 18, 2024
CODX Price
$1.16
Fair Value Price
$0.08
Market Cap
$36.26M
52 Week Low
$0.98
52 Week High
$1.89
P/E
-0.97x
P/B
0.42x
P/S
5.73x
PEG
N/A
Dividend Yield
N/A
Revenue
$6.81M
Earnings
-$35.33M
Gross Margin
38.6%
Operating Margin
-559.46%
Profit Margin
-518.7%
Debt to Equity
0.11
Operating Cash Flow
-$22M
Beta
0.07
Next Earnings
May 9, 2024
Ex-Dividend
N/A
Next Dividend
N/A
CODX Overview
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CODX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CODX ($1.16) is overvalued by 1,349.43% relative to our estimate of its Fair Value price of $0.08 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CODX ($1.16) is not significantly undervalued (1,349.43%) relative to our estimate of its Fair Value price of $0.08 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CODX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CODX due diligence checks available for Premium users.
Be the first to know about important CODX news, forecast changes, insider trades & much more!
CODX News
Valuation
CODX fair value
Fair Value of CODX stock based on Discounted Cash Flow (DCF)
Price
$1.16
Fair Value
$0.08
Overvalued by
1,349.43%
CODX ($1.16) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CODX ($1.16) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CODX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
CODX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.97x
Industry
28.61x
Market
41.33x
CODX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.42x
Industry
3.63x
CODX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CODX's financial health
Profit margin
Revenue
$3.6M
Net Income
-$14.7M
Profit Margin
-412.8%
CODX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CODX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$95.3M
Liabilities
$9.3M
Debt to equity
0.11
CODX's short-term assets ($62.14M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CODX's short-term assets ($62.14M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CODX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CODX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$4.8M
Investing
$9.6M
Financing
-$159.7k
CODX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CODX vs Medical Device Stocks
Co Diagnostics Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.